Led · Equity · Oct 2025

Panda Surgical is a London-based medical device company building a novel handheld robotic system intended for confined-space neurosurgery. Its platform pairs the familiarity of manual tools with detachable, wristed robotic instruments as small as 3 mm in diameter, aiming to let surgeons perform more precise and complex brain and spine operations. Recent milestones include successful worldwide cadaver labs, animal trials, and the expansion of its patent portfolio. The company plans to apply its latest funding toward its first-in-human clinical investigation and continued product development. Leadership believes the technology can broaden global access to advanced surgical care by shrinking the cost and footprint of traditional robotics. Although still pre-revenue, Panda Surgical’s early clinical and technical validation has attracted both institutional and strategic clinician investors.

Participated · Series A · Apr 2023

Caristo Diagnostics completed a US$16.3M Series A to advance its imaging-based, AI-assisted diagnostic platforms. The company plans to use the funds to advance its CaRi-Heart technology into standards of cardiac care in global markets. Caristo is a 2018 University of Oxford spin-out based in Oxford, UK, led by CEO Frank Cheng. Its core product, CaRi-Heart, applies AI algorithms to routine cardiac computed tomography angiography (CCTA) scans to obtain measures of coronary inflammation using a Fat Attenuation Index (FAI) technology. The resulting FAI Score measures the risk of cardiac mortality due to coronary inflammation, and CaRi-Heart also provides a long-term cardiac mortality risk by integrating coronary inflammation with standard clinical risk factors and the presence of coronary plaques. The announcement did not disclose operating metrics.

Participated · Series A · Jul 2022

Brill Power develops a combination of hardware and intelligent software to optimise battery management and increase lifetime performance, safety, and usable energy of lithium‑ion packs. The company says its optimised Active Loading method can increase battery life by up to 60% and allow used batteries to discharge up to 46% more energy. Its technology is applied across stationary energy storage, office and industrial buildings, on‑ and off‑grid systems, residential structures, and electric vehicles. After raising $10.5M in a Series A, Brill plans to double its engineering and commercial teams and expand its product range for static storage and the EV market. Proceeds will also fund further development of BrillAnalytics, a data platform for remote monitoring and forecasting of battery safety, health, and performance. Brill was founded in 2016 as an Oxford University spin‑out and has projects with Aston Martin, AMTE Power, and Delta Cosworth. Brill Power develops a solution that improves energy storage by enabling control of each individual lithium‑ion cell within battery packs. The technology is positioned to increase reliability and efficiency of batteries used to store renewable energy. The company won this year’s New Energy Challenge in Amsterdam, an outcome that the team described as validation of their approach. Brill Power received a €100,000 convertible loan and a year of business advice as part of the prize. Company representatives highlighted the value of interaction and collaboration with specialists, jury members and other startups during the programme. The startup plays into broader efforts to fast‑track development and commercialization of new energy solutions. No operating metrics or prior funding amounts were disclosed in the article.

Participated · Series A · Jul 2022

Oxford Quantum Circuits, founded as a spinout from Oxford University in 2017 and based in Reading, develops superconducting quantum computing hardware and supporting software. The company deploys its machines in data centres and offers access to customers and researchers as a cloud service. OQC targets business and government customers, citing demand from financial services, defence and security companies for secure quantum technology. It positions itself to move from long-term promise toward near-term commercial delivery and plans to scale internationally and advance its technology roadmap. The company recently strengthened its financial position by raising a £260 million Series C to accelerate commercialization and market expansion. No revenue or user metrics were disclosed in the provided article.

Participated · Seed · May 2022

Salience Labs develops silicon photonics optical switches to connect AI datacenter clusters, targeting high bandwidth, low latency and significant power savings. Its switches are designed to be compatible with existing infrastructure and enable scalable, energy-efficient interconnect fabrics for large AI clusters. The company draws on over a decade of research from the University of Oxford and the University of Münster and was founded in 2021 in Oxford, England. Salience plans to further develop its optical switches, bring products to customers, and expand to the U.S. to serve key customers. It recently closed a $30 million Series A to accelerate development and go-to-market; no revenue or user metrics were disclosed in the article. Salience Labs develops an ultra-high-speed multi-chip processor that packages a photonics chip with standard electronics to accelerate AI computation. Its proprietary “on-memory compute” architecture combines the speed of photonics, the flexibility of electronics, and the manufacturability of CMOS. The company says its approach uses a broad bandwidth of light to execute operations and can stack up to 64 vectors into a beam, enabling highly scalable, densely parallel processing. Salience positions the technology as delivering far more calculation for the same power requirement, targeting more efficient AI systems. The company spun out of Oxford University and the University of Münster in 2021 and is based in Oxford. It recently raised funding to advance development and scaling of its photonics-enabled processors.